Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Advanced ceramics are starting to become adopted at a rapid pace to coat metals (This year) - just look at S&N. Coatings have been a focus of many of the conferences and keynotes this year. Competitors will also adopt similar tech, and Sintx holds the patent and the only medically cleared si3n4 with R&D to back it up. It's a no brainer they will be acquired, and likely soon.
Suppressed share price among other indicators to me express a company getting ready to sell. I think the R/S will be much to do about nothing. If anything it's a way to buy them more time as things come together.
ya man, I just recently changed my vote to a no. I've went back and forth on this, but I really see zero reason to R/S at this stage. If they have a deal they are lining up, time to announce it and move this product into more hands which I see happening regardless - the need in the industry is too great. The share price will resolve itself.
I don't know why you bring in a guy like this before you have money unless there is some big opportunity coming...Like a Harris Corp Collaboration.
At this price couldn't CTL just wink and buy Sint for half of what their revs will be from the product they just bought from them? Crazy. So undervalued given their debt and cash levels.
Time is now Sonny, make a move! Get this product in more hands and put to rest the concerns about compliance.
The ceramic oxide that smith and nephew presented on demonstrated clear advantages. Not sure how this is a bad thing. It would actually mean that companies are moving in this direction and si3N4 is a biomaterial that checks all the marks that surgeons are looking for in future tech (also presented on) - antibacterial being repeated over an over to reduce possibility of infection. A competitor to S&N would certainly see interest in Sintx technology wouldn't you say? Of course if said competitor isn't already working with them . Typically these things wouldn't happen over night, it's reasonable to expect that if S&N is integrating this tech, then competitors are already working with other companies to implement something better or to compete with it.
I've got to believe the lower this goes the closer this gets to a merger/BO. OMTEC clearly demonstrated the future impact of coatings and on many 'want lists' were the properties that only si3n4 can provide. This was a centerpiece of the show. I can't see how this goes lower and is not on anyone radar.
Has this ever NOT gone up before an R/S? Seems clear as day this is being kept down for some reason. Still a few days left to find out.
So if S&N have their solution (they get it and directly compare to CoCR in their presentation), when are we going to see the Si3N4 competitor response?...Looks like Zimmer had a nice supply chain and commodities presence at OMTEC which is interesting given the timing of the Sintx hires. Given the multiple presentations on coatings and replacements there certainly appears to be a strong need for the properties that only Si3N4 can provide.
Isn't it strange they haven't released any sort of news before the SH meeting? Doesn't appear they seem to care too much about the current SP levels prior to such a crucial vote. Hmm.
correct, i'm not talking about R&D (PL/OEM) My guess is it's someone like Zimmer co-developing with them on Hip, separate work stream.
Margins are lower for private label/OEM so they would have to hire to scale more effectively for something like defense application. Contracts could be significant and I certainly see them ramping up for this. Hence the supply chain help and urgency in the hires. R&D is likely going toward Hip, Dental, Spinal fusion which is clearly laid out in the filings, among other common expenses - this is what I see the offering for. The next half of the year is going to be veeeery interrrresting!
Hello Harris Corp, meet Si3N4.
Ask yourself, what's the market cap now with no debt and COH vs. the market cap with no debt, COH, and a commercialization agreement. Ask yourself, why would they protect the IP on the Weigo deal, when that deal alone was worth 20-30x the current market cap - not to mention if they were really planning on selling the IP (as explored on the CTL CC) then why wouldn't they just take the Weigo deal regardless of IP protection. There is something bigger here.
It's not rocket science. They can't scale internally to support demand at large, but they would still need to work with said partners on scaling right? Therefore they need to hire people with supply chain expertise.
I mean isn't that all that is really left to do here? The crappy stuff is over with, now we see if they can actually execute on a superior product and create some growth and get it in more hands via these partnerships. I don't really look at the RS as a bad thing as long as they deliver at this stage where they are at. Of course I am holding out hope it doesn't happen at all.
I've got some very grand thoughts as to what is happening but I'll just keep that to myself. Medtronic would absolutely benefit. Things should heat up now after this offering.
Money now in hand, ISO 13485 audit was successfully completed..Ready to scale for growth, lets do this! C'mon Sonny Release the news!
Anyone find it interesting that Medtronic is the only company who is in part organizing for the ACS Next Gen Bioceramics and biocomposites Symposium? This is what Sintx just retweeted for.
I’d be surprised if we don’t hear something this week.
One would think it’s on the sec radar. It certainly drew enough attention. We’ll see.
So many things happening prematurely. You have to ask yourself, why? Can’t believe folks aren’t picking up on the clues I’m seeing.
Much higher risk to short the RS on a company with this many catalysts, no debt, and plenty of cash. This company has had a long term vision for quite some time and it’s about to come full circle. I’m very excited about it. It’s unfortunate the first half took so long and cost so much but can’t say I’m surprised. This industry has been a mess for years.
There are folks that will look at the present, the past etc. You have to look at the big picture. The current offering sucks for traders as usual who have done zero DD, but does nothing for longs. Nothing changes. Bigger float? Big deal. Lower share price? Thanks I’ll take some more cheapies. Company now has even more cash, no debt, and some major upcoming catalysts that you can easily see if you do your DD. This was the only negative on their roadmap for the remainder of the year.
Ya I see coatings being a very significant draw and rev generator, not just for CTL. I wonder how they’ll price it.
Why would they do an offering before they even get shareholder approval for the RS? Doesn't seem like a very good strategy if you want shareholder votes.
There's much more going on here with their partners obviously.
A no debt company raising money to keywords 'scale up manufacturing'. The only reason you do this is because there is an increase in demand coming.
Here's some of the 'smaller' clues. 1. They hired a bunch of new key resources (before any money coming in) 2. They renewed their lease for 5 years. 3. They say they need to scale manufacturing, (for what?). 4. CTL has now completely absorbed their product line and is selling, they have updated their website to reflect. Growth is coming.
Sheesh, it is so obvious what is happening here. Big picture folks, big picture.
Yep, this is why I had mentioned I'd expect sometime in August. Deadline is Sept.
This is peanuts, and was spelled out in the filings. The R/S is much more worrisome to me. For any shareholders who have been here as long as I have, we have seen much much worse. They are in a very good position, and have 90% of their strategic roadmap to fill before year end.
Thanks for pointing this out, watched it last night and was awesome. Word is getting out, and companies will need to innovate and move away from metal exposure. I can't wait until they give this tech the green light, i'm literally counting the days.
Yep exactly. With the RTM deals are lined up. If this happens to turn into a buyout, it's more likely we see commercialization and revs jump prior. Just my thoughts anyway. We'll see what pans out, there are def some things i'm seeing, which is why I voted yes.
The recent hires have been very strategic even dating back to Ryan and Dana. There is a pretty clear picture forming here if you look at the big picture. WS just isn't there yet with the valuation. They are looking at COH without factoring in IP or commercialization because it hasn't happened yet, but I have a hard time believing this will remain the case for much longer.
I would expect patent by sometime in August if not before. And regarding Zimmer, I find it hard to believe it's anyone but Zimmer simply because this company is dirt cheap right now - and if they weren't tied up with some other party doing something, I can't see how they would still be on the market.
Who in their right mind hires more talent prior to raising more cash if Future COH was any concern. Think about it.
Love it! and they are well positioned. I'm VERY confident we see the revenue rise from here. The RS is the only wild card for me, not worried about cash levels, they'll want to keep things clean.
I'll be voting yes. I will also be buying more, heavily. My DD is showing me some pretty exciting strategic initiatives, if played correctly this RS will be minimized or there will be no need. Its a risk, but I see enough potential in the short term.